SCHEMBL3663002

SCHEMBL3663002

NC(=O)N(S)c1cc(Br)ccc1Br

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.38
HSP90AA1 P07900 1/20 0.36
TLR9 Q9NR96 1/20 0.36
PARP1 P09874 1/20 0.36
KDM4E B2RXH2 1/20 0.35
GLA P06280 1/20 0.35
ALOX5 P09917 2/20 0.35
PLAU P00749 1/20 0.34
ALOX15 P16050 2/20 0.33
CES2 O00748 1/20 0.33
GALR3 O60755 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
CASP1 P29466 1/20 0.33
CYP2C19 P33261 1/20 0.33
S100A4 P26447 1/20 0.32
SIGMAR1 Q99720 2/20 0.32
LMNA P02545 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3039158 0.78 SLC9A1 (0.41) KDM4ECYP1A2CYP2C9HPGDCYP2C19
SCHEMBL4920991 0.72 ALOX5 (0.43) KDM4EALOX5PLAUCES2HPGD
SCHEMBL5634705 0.70 PARP1 (0.48) DGAT1PARP1CYP1A2HPGDALDH1A1
SCHEMBL3660051 0.69 KIF11 (0.34) DGAT1
SCHEMBL219166 0.68 PARP1 (0.32) DGAT1PARP1KDM4EGLAALOX5
SCHEMBL4983120 0.67 S100A4 (0.50) ALOX5CYP1A2S100A4
SCHEMBL3980811 0.66 SLC1A3 (0.41) DGAT1TLR9CYP1A2CYP2C9CYP2C19
SCHEMBL29435112 0.66 DGAT1 (0.59) DGAT1HSP90AA1TLR9PARP1KDM4E
SCHEMBL2853526 0.66 DGAT1 (0.59) DGAT1HSP90AA1TLR9PARP1KDM4E
SCHEMBL2659434 0.66 GBA1 (0.44) KDM4EALOX5PLAUALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231653-B1 ANTIBACTERIAL CONDENSED THIAZOLES BIOTA EUROPE LTD (GB) 2013-04-03 EP disclosed
US-8299065-B2 Antibacterial condensed thiazoles BIOTA EUROPE LTD. (GB) 2012-10-30 US disclosed
US-20100305067-A1 ANTIBACTERIAL CONDENSED THIAZOLES BIOTA EUROPE LTD (GB) 2010-12-02 US disclosed
EP-2231653-A1 ANTIBACTERIAL CONDENSED THIAZOLES Biota Europe Ltd (GB) 2010-09-29 EP disclosed
WO-2009074812-A1 ANTIBACTERIAL CONDENSED THIAZOLES PROLYSIS LTD (GB) 2009-06-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305067-A1 ANTIBACTERIAL CONDENSED THIAZOLES NEK6, NEK1, TXK DGAT1 2534/4885HSP90AA1 2821/4885TLR9 587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.